| Announce Date | 11/07/2025 |
| EPS Normalized Actual | $0.08 (Miss by $-0.05) |
| EPS GAAP Actual | $0.08 (Miss by $-0.05) |
| Revenue Actual | $4.399B |
| Revenue Surprise | Beat by $4399M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.34319 |
| EPS GAAP Estimate | $0.34319 |
| Revenue Estimate | $4.785169476B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0.96 | 12.88 | 0.91243 | 1.01871 | 10 |
| Dec 2028 | 1.12 | 11.04 | 1.00444 | 1.2425 | 9 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.06 | -0.23851 | 4.399B | -5.8% | -424.55M |
| FQ2 2025 (Jun 2025) | 0.18 | -0.19197 | 4.711B | -16.54% | -541.46M |
| FQ1 2025 (Mar 2025) | 0.1 | -0.19178 | 3.828B | 100% | -667.21M |
| FQ4 2024 (Dec 2024) | 0.14 | -0.22206 | 4.876B | 100% | -528.48M |
| FQ3 2024 (Sep 2024) | 0.24 | -0.0581 | 4.654B | 100% | -9.55M |
| FQ2 2024 (Jun 2024) | 0.34 | 0.34 | 5.49B | 100% | 5490M |
| FQ3 2012 (Sep 2012) | 0.27 | 0.27 | 8.10596B | 100% | 8105.96M |
| FQ4 2012 (Dec 2012) | -0.0621 | -0.0621 | 8.69884B | 100% | 8698.84M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.34319
Consensus Revenue Estimates
4.785169476B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.35063 | -- | 0.35063 | 0.35063 | 5 |
| FQ3 2027 (Sep 2027) | 0.32165 | -- | 0.31756 | 0.3273 | 7 |
| FQ2 2027 (Jun 2027) | 0.30429 | -- | 0.30043 | 0.30964 | 6 |
| FQ1 2027 (Mar 2027) | 0.22309 | -- | 0.22309 | 0.22309 | 5 |
| FQ4 2026 (Dec 2026) | 0.3919 | -- | 0.35209 | 0.43376 | 9 |
| FQ3 2026 (Sep 2026) | 0.32947 | 81.79 | 0.296 | 0.36466 | 6 |
| FQ2 2026 (Jun 2026) | 0.39026 | 53.88 | 0.35062 | 0.43195 | 4 |
| FQ1 2026 (Mar 2026) | 0.34319 | 70.86 | 0.30833 | 0.37985 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 6.61B | -- | 6.61B | 6.61B | 1 |
| FQ3 2027 (Sep 2027) | 6.03B | -- | 5.98B | 6.12B | 2 |
| FQ2 2027 (Jun 2027) | 6.08B | -- | 6.02B | 6.16B | 2 |
| FQ1 2027 (Mar 2027) | 4.93B | -- | 4.93B | 4.93B | 1 |
| FQ4 2026 (Dec 2026) | 6.06B | -- | 5.58B | 6.55B | 3 |
| FQ3 2026 (Sep 2026) | 5.26B | 16.37 | 4.85B | 5.69B | 3 |
| FQ2 2026 (Jun 2026) | 5.65B | 16.58 | 5.21B | 6.11B | 4 |
| FQ1 2026 (Mar 2026) | 4.79B | 20 | 4.41B | 5.18B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
3
Revenue # of Misses
5
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.29851 | 0.06 | -0.23851 | -397.52% |
| FQ2 2025 (Jun 2025) | 0.37197 | 0.18 | -0.19197 | -106.65% |
| FQ1 2025 (Mar 2025) | 0.29178 | 0.1 | -0.19178 | -191.78% |
| FQ4 2024 (Dec 2024) | 0.36206 | 0.14 | -0.22206 | -158.61% |
| FQ3 2024 (Sep 2024) | 0.2981 | 0.24 | -0.0581 | -24.21% |
| FQ2 2024 (Jun 2024) | 0.34 | 0.34 | 100% | |
| FQ3 2012 (Sep 2012) | 0.27 | 0.27 | 100% | |
| FQ4 2012 (Dec 2012) | -0.0621 | -0.0621 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $4.82B | $4.4B | $-424.55M | -9.65% |
| FQ2 2025 (Jun 2025) | $5.25B | $4.71B | $-541.46M | -11.49% |
| FQ1 2025 (Mar 2025) | $4.5B | $3.83B | $-667.21M | -17.43% |
| FQ4 2024 (Dec 2024) | $5.4B | $4.88B | $-528.48M | -10.84% |
| FQ3 2024 (Sep 2024) | $4.66B | $4.65B | $-9.55M | -0.21% |
| FQ2 2024 (Jun 2024) | $0B | $5.49B | $5490M | 100% |
| FQ3 2012 (Sep 2012) | $0B | $8.11B | $8105.96M | 100% |
| FQ4 2012 (Dec 2012) | $0B | $8.7B | $8698.84M | 100% |